Ageas Federal Life Insurance launches multicap fund in ULIP portfolio; details here

The recently launched multicap fund offers customers the opportunity for strong capital appreciation returns.

Abeer Ray
Published6 Feb 2024, 07:11 PM IST
Ageas Federal Life Insurance launches a new multicap fund.
Ageas Federal Life Insurance launches a new multicap fund.

Ageas Federal Life Insurance (AFLI) has introduced multicap fund within its Unit Linked Insurance Plan (ULIP) portfolio. This open-ended fund aims to generate returns through strategic investments in a diverse range of listed companies across different market capitalisations.

“We are excited to present a new addition to our ULIP portfolio, targeting capital appreciation returns via diversified investments across various market caps. Our commitment to providing innovative and value-driven solutions is reinforced with the introduction of the Multicap Fund. This strategic addition to our ULIP portfolio aims to deliver attractive returns for our customers while ensuring diversification and risk management,” said Vighnesh Shahane, MD & CEO, Ageas Federal Life Insurance.

Investment details

"The launch of the Multicap Fund underscores Ageas Federal Life Insurance's continuous efforts to enhance its product offerings and meet the evolving financial needs of its customers,” Shahane added.

Effective from February 5, 2024, the multicap fund will be integrated into the following products:

• Platinum Wealth Builder

• Smart Growth Plan

• Wealthsurance SP II

Benefits of putting money into ULIPs

Investing in ULIPs combines the advantages of life insurance and investment. This entails securing life coverage for your loved ones in the event of your unfortunate passing, along with the potential to enhance your wealth through market-linked investments.

The advantages of putting your money into these ULIPs are:

  • Dual advantage: Obtain both life insurance protection and investment opportunities within a single plan.
  • Investment versatility: Select from a range of equity, debt, or balanced funds tailored to your risk tolerance and objectives.
  • Market-linked returns: Potential for increased returns compared to conventional insurance plans.
  • Tax advantages: Premiums paid and maturity proceeds (under specified conditions) qualify for tax benefits.
  • Goal-oriented planning: Ideal for achieving long-term financial objectives such as retirement, funding a child's education, or purchasing a home.
  • Flexibility: Certain ULIPs permit fund switching and partial withdrawals during the lock-in period.

Crafted to facilitate capital growth, the multicap fund strategically invests in a selected mix of established blue-chip companies, emerging blue-chip companies, mid-cap companies, and chosen small-cap companies. Prioritising the medium to long term, the fund seeks to mitigate risks by diversifying investments across different sectors, offering customers a well-rounded and potentially lucrative investment approach.

 

Catch all the Instant Personal Loan, Business Loan, Business News, Money news, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:6 Feb 2024, 07:11 PM IST
Business NewsMoneyPersonal FinanceAgeas Federal Life Insurance launches multicap fund in ULIP portfolio; details here

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    Vedanta share price

    472.05
    03:59 PM | 17 OCT 2024
    -14.75 (-3.03%)

    Tata Steel share price

    152.35
    03:58 PM | 17 OCT 2024
    -2.9 (-1.87%)

    Bharat Petroleum Corporation share price

    342.50
    03:55 PM | 17 OCT 2024
    -8.35 (-2.38%)

    Tata Power share price

    450.05
    03:41 PM | 17 OCT 2024
    -10.3 (-2.24%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    Coforge share price

    7,120.75
    10:51 AM | 7 OCT 2024
    -2.4 (-0.03%)

    Vijaya Diagnostic Centre share price

    984.80
    10:51 AM | 7 OCT 2024
    -4.15 (-0.42%)

    Dr. Lal Pathlabs share price

    3,408.00
    10:50 AM | 7 OCT 2024
    -86.25 (-2.47%)
    More from 52 Week High

    Bombay Burmah Trading Corporation share price

    2,519.95
    10:51 AM | 7 OCT 2024
    -245.3 (-8.87%)

    Jubilant Ingrevia share price

    728.55
    10:51 AM | 7 OCT 2024
    -65.7 (-8.27%)

    Triveni Engineering & Indus share price

    426.65
    10:51 AM | 7 OCT 2024
    -35.75 (-7.73%)

    Vodafone Idea share price

    9.08
    10:51 AM | 7 OCT 2024
    -0.72 (-7.35%)
    More from Top Losers

    Astrazeneca Pharma India share price

    7,832.35
    10:51 AM | 7 OCT 2024
    399.85 (5.38%)

    Finolex Industries share price

    280.85
    10:51 AM | 7 OCT 2024
    9.2 (3.39%)

    Macrotech Developers share price

    1,206.20
    10:51 AM | 7 OCT 2024
    34.35 (2.93%)

    JK Lakshmi Cement share price

    797.60
    10:51 AM | 7 OCT 2024
    17.2 (2.2%)
    More from Top Gainers

      Recommended For You

        More Recommendations

        Gold Prices

        • 24K
        • 22K

        Fuel Price

        • Petrol
        • Diesel
        Bangalore
        102.86/L0.00
        Chennai
        100.85/L0.00
        Kolkata
        104.95/L0.00
        New Delhi
        94.72/L0.00

        Popular in Money

          HomeMarketsloanPremiumMint Shorts